| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.5M | — | -16.5% |
| R&D Expense | $36.6M | — | -29.2% |
| SG&A Expense | $7.6M | — | -42.9% |
| Operating Income | -$29.7M | — | +56.7% |
| Pre-tax Income | -$38.5M | — | +49.3% |
| Income Tax | -$15K | — | -314.3% |
| Net Income | -$38.5M | — | +49.3% |
| EPS (Basic) | -$2.94 | — | -223.1% |
| EPS (Diluted) | -$2.94 | — | -223.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $73.7M | +26.8% | -30.6% |
| Short-term Investments | $128.9M | +54.7% | -9.7% |
| Accounts Receivable | $12.5M | +213.9% | -7.9% |
| Current Assets | $221.0M | +46.4% | -23.1% |
| Total Assets | $242.0M | +39.2% | -24.7% |
| Current Liabilities | $70.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$42.3M | — | +37.7% |
| Investing Cash Flow | -$45.3M | — | -178.4% |
| Financing Cash Flow | $103.1M | — | — |
| -46.8% |
| Total Liabilities | $308.9M | +0.8% | -11.0% |
| Stockholders' Equity | -$66.9M | +49.5% | -159.1% |